0.7187
Tevogen Bio Holdings Inc stock is traded at $0.7187, with a volume of 96,659.
It is up +0.31% in the last 24 hours and down -17.14% over the past month.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
See More
Previous Close:
$0.7151
Open:
$0.71
24h Volume:
96,659
Relative Volume:
0.11
Market Cap:
$141.12M
Revenue:
-
Net Income/Loss:
$52.50M
P/E Ratio:
24.70
EPS:
0.0291
Net Cash Flow:
$-4.13M
1W Performance:
+10.56%
1M Performance:
-17.14%
6M Performance:
-33.58%
1Y Performance:
+88.96%
Tevogen Bio Holdings Inc Stock (TVGN) Company Profile
Name
Tevogen Bio Holdings Inc
Sector
Industry
Phone
646-807-8832
Address
15 INDEPENDENCE BOULEVARD, SUITE #210, WARREN
Compare TVGN with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
TVGN
Tevogen Bio Holdings Inc
|
0.7174 | 140.66M | 0 | 52.50M | -4.13M | 0.0291 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.82 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
459.48 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
545.00 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
796.73 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
325.17 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Tevogen Bio Holdings Inc Stock (TVGN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Mar-04-25 | Initiated | D. Boral Capital | Buy |
Tevogen Bio Holdings Inc Stock (TVGN) Latest News
Applying Elliott Wave Theory to Tevogen Bio Holdings Inc. Equity WarrantWeekly Risk Summary & Smart Allocation Stock Reports - newser.com
Tevogen Bio Holdings Inc. Equity Warrant stock chart pattern explainedWeekly Loss Report & Fast Moving Trade Plans - newser.com
Tevogen Bio Holdings Inc. stock outlook for YEARNew Guidance & Verified Trade Idea Suggestions - newser.com
Is it time to cut losses on Tevogen Bio Holdings Inc.2025 Technical Overview & Risk Controlled Swing Trade Alerts - newser.com
Analyzing recovery setups for Tevogen Bio Holdings Inc. investorsTrade Signal Summary & Free Fast Entry Momentum Trade Alerts - newser.com
Reversal indicators forming on Tevogen Bio Holdings Inc. stockWeekly Loss Report & Free Real-Time Market Sentiment Alerts - newser.com
Real time scanner hits for Tevogen Bio Holdings Inc. Equity Warrant explainedRate Cut & Low Drawdown Momentum Trade Ideas - newser.com
What drives Tevogen Bio Holdings Inc G28 stock priceStochastic Oscillator Alerts & Free Daily Market Summary and Trend Reports - earlytimes.in
Will Tevogen Bio Holdings Inc. Equity Warrant outperform the marketJuly 2025 PostEarnings & Community Consensus Trade Alerts - newser.com
Published on: 2025-10-10 09:21:27 - newser.com
Price action breakdown for Tevogen Bio Holdings Inc.Market Activity Report & Entry Point Confirmation Signals - newser.com
Tevogen Bio Holdings Inc. Equity Warrant recovery potential after sell offJuly 2025 Summary & Free Daily Entry Point Trade Alerts - newser.com
Tevogen Bio Holdings Inc. Equity Warrant stock momentum explained2025 Price Targets & Free Real-Time Volume Trigger Notifications - newser.com
Technical signs of recovery in Tevogen Bio Holdings Inc. Equity WarrantJuly 2025 Action & Risk Controlled Stock Alerts - newser.com
Candlestick signals on Tevogen Bio Holdings Inc. stock todayJuly 2025 Action & Weekly Return Optimization Alerts - newser.com
Tevogen Bio's (TVGN) "Sell (E+)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Detecting price anomalies in Tevogen Bio Holdings Inc. Equity Warrant with AITrade Risk Summary & High Accuracy Trade Alerts - newser.com
Using Ichimoku Cloud for Tevogen Bio Holdings Inc. Equity Warrant technicalsIndex Update & Advanced Swing Trade Entry Plans - newser.com
Can a trend reversal in Tevogen Bio Holdings Inc. Equity Warrant lead to recoveryMarket Activity Summary & Free High Return Stock Watch Alerts - newser.com
Is it too late to sell Tevogen Bio Holdings Inc. Equity WarrantEarnings Miss & High Conviction Investment Ideas - newser.com
What makes Tevogen Bio Holdings Inc. stock attractive to growth funds2025 Key Highlights & Risk Controlled Stock Alerts - newser.com
Why Tevogen Bio Holdings Inc. stock remains a top recommendationJuly 2025 PreEarnings & AI Enhanced Trade Execution Alerts - newser.com
Can trapped investors hope for a rebound in Tevogen Bio Holdings Inc.Portfolio Performance Report & Weekly Breakout Stock Alerts - newser.com
Will Tevogen Bio Holdings Inc. stock see PE expansionInsider Selling & AI Enhanced Trading Alerts - newser.com
Is Tevogen Bio Holdings Inc. (G28) stock attractive post correctionJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
Is Tevogen Bio Holdings Inc Equity Warrant a good long term investmentAnalyst Downgrades & Big Profit Low Investment - earlytimes.in
Applying chart zones and confluence areas to Tevogen Bio Holdings Inc. Equity WarrantQuarterly Performance Summary & Risk Adjusted Swing Trade Ideas - newser.com
Why Tevogen Bio Holdings Inc. (G28) stock could break out in 2025Earnings Growth Summary & Reliable Price Breakout Signals - newser.com
What data driven models say about Tevogen Bio Holdings Inc.’s futureStock Surge & Free Safe Entry Trade Signal Reports - newser.com
How to build a custom watchlist for Tevogen Bio Holdings Inc.Market Sentiment Report & Free Low Drawdown Momentum Trade Ideas - newser.com
What analysts say about Tevogen Bio Holdings Inc stockSmall Cap Stock Opportunities & Start Your Free Trading Journey Today - earlytimes.in
How high can Tevogen Bio Holdings Inc. stock go2025 Short Interest & Daily Profit Focused Screening - newser.com
Tevogen Bio (NASDAQ:TVGN) Trading Down 0.3%Time to Sell? - MarketBeat
Tevogen Bio Holdings Inc Stock (TVGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):